Standout Papers

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study 2018 2026 2020 2023 267
  1. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study (2018)
    Giuseppe Giaccone, Chul Kim et al. The Lancet Oncology

Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 24

Citing Papers

Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
Prevalence of cancer survivors in the United States
2024 Standout
2 intermediate papers

Works of Jillian Thompson being referenced

Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control
2019
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
2018 Standout

Author Peers

Author Last Decade Papers Cites
Jillian Thompson 26 219 76 161 9 329
Mamta Joshi 29 98 140 160 12 349
Anupama Kurup 70 116 70 105 7 261
Barbara Scepura 110 113 87 84 8 281
Janet Lasher 15 135 45 185 8 331
Patrick R. Bergevin 61 115 18 114 12 327
H.R. Marcuse 34 136 63 42 10 315
Hendrik Blaeker 52 210 119 35 14 318
Brian Shaw 64 42 55 79 8 340
Sheetal Shroff 44 123 10 197 10 286
C‐C Pan 102 70 46 108 6 326

All Works

Loading papers...

Rankless by CCL
2026